Navigation Links
American Heart Association Rapid Access Journal Report: Implanted Monitor Accurately Detects Heart Rhythm Disturbances
Date:2/17/2010

Study highlights:

- Researchers report a more accurate way to detect and assess irregular heartbeats which can cause blood clots to form.

- Using this new technology can help healthcare providers assess patients who do not experience symptoms related to the heart rhythm disturbance called atrial fibrillation.

DALLAS, Feb. 17 /PRNewswire-USNewswire/ -- Doctors soon may be able to more accurately monitor heart rhythm disturbances and gauge the severity of atrial fibrillation (AF) with a new algorithm used in the Reveal XT leadless implantable heart monitor, according to research reported in Circulation: Arrhythmia and Electrophysiology, a journal of the American Heart Association.

"Patients with atrial fibrillation may be at significant risk for severe cardiovascular events due to the presence of the arrhythmia," said the study's lead author, Gerhard Hindricks, M.D., Ph.D., who is also a professor at the Heart Center of the University of Leipzig in Germany.

Detecting AF -- and adequately treating it -- is crucial, Hindricks said, because patients often don't have symptoms.

Some 2.2 million Americans have AF, in which the heart's two upper chambers -- the atria -- quiver instead of beating effectively.  Blood isn't completely pumped out of them, so it may pool and clot, raising the risk of stroke.  Roughly one in seven strokes occur in people with AF, according to American Heart Association statistics.

In the study, 247 patients suspected of having sporadic irregular heart rhythms were implanted with the Reveal XT monitor and outfitted with a Holter monitor.  This allowed researchers to compare heartbeats recorded by each monitor for the 46-hour study period.  The Reveal XT monitor, which is the size of a camera's memory stick, was inserted just under a patient's skin using local anesthesia.  A Holter monitor is commonly used to detect AF.  It has wires attached to the chest and is worn on the waist much like a music player.

The study enrolled patients from 24 medical centers, mainly in Europe and Canada.  Patients had an average age of 57, and 67 percent were men.  About 10 percent had a history of stroke or transient ischemic attack.

The researchers found that the new computation method with the Reveal monitor was highly sensitive, correctly detecting AF in 96.1 percent of all patients with AF.  

"Even with repetitive, seven-day Holter monitoring, atrial fibrillation may not be detected in a significant number of patients," said Hindricks.  He expects the new device to be used as a way to assess treatment of patients.  "Only continuous long-term rhythm monitoring will be able to precisely define the rhythm outcome or efficacy of such treatment," he said.

Hindricks added that further studies are needed to determine the longer-term accuracy of the Reveal monitor.  "The device has a limited data storage capacity (49.5 minutes of data), and this may be a limitation during longer follow-up periods -- especially since the presence of false positive episodes may exceed the storage capacity in some patients.  Thus, long-term performance and validation studies are needed to find the optimal way of handling the device."  

Medtronic funded the study.

Co-authors are: Evgueny Pokushalov, M.D.; Lubos Urban, M.D.; Milos Taborsky, M.D., Ph.D.; Karl-Heinz Kuck, M.D., Ph.D.; Dmitry Lebedev, M.D., Ph.D.; Guido Rieger, M.D.; and Helmut Purerfellner, M.D.  Author disclosures are on the manuscript.

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position.  The association makes no representation or guarantee as to their accuracy or reliability.  The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events.  The association has strict policies to prevent these relationships from influencing the science content.  Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.

SOURCE American Heart Association

RELATED LINKS
http://www.americanheart.org

'/>"/>

SOURCE American Heart Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in Ohio Today
2. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in Michigan Today
3. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in Massachusetts Today
4. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in North Carolina Today
5. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in Missouri Today
6. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in Pennsylvania Today
7. The American Academy of Pain Medicine Announces this Years Presidential Commendations and Awards
8. Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility
9. Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowleys American Scene Radio Program and Featured on Money Channel Inc.
10. CORD:USE Cord Blood Bank Congratulates Team Member Hal Broxmeyer, Ph.D., on his Election as President of the American Society of Hematology
11. AHRQ and American College of Cardiology Collaborate On Study of Implantable Cardioverter Defibrillators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... According to a new ... Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical Chemistry, ... Infectious Diseases) - Forecast to 2021" published by ... 60.22 Billion in 2016. This market is expected ... the forecast period (2016-2021) to reach USD 78.74 ...
(Date:12/2/2016)... On Thursday, December 1st 2016, the Prix ... and innovation in the biopharmaceutical industry at its third ... presence of Sergey Tsyb, Vice Minister of Industry and ... Natalia Sanina, First Vice Chairman of the State Duma ... National Service of Control in Healthcare, Sergey Muravev, Director ...
(Date:12/2/2016)... , December 2, 2016 bioLytical Laboratories, ein Weltführer ... bei den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... office, will speak at the American Conference Institute’s 21st Drug & Medical Device ... a Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical ...
(Date:12/2/2016)... ... 2016 , ... Advanced Inc., a leading provider of travel therapy and travel ... serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served ... and operational leadership experience to Advanced Inc. He began his career in finance at ...
(Date:12/2/2016)... PITTSBURGH, PA (PRWEB) , ... December 02, 2016 , ... ... or struggling through rehabilitation of an injury, patients must find the one that works ... for his pain, he created a machine that worked and decided to share it ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and ... storing, shipping and disposal. The new version is a faster and a more ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):